A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone

Introduction: Gestational diabetes (GD) is one of the most common medical complications of pregnancy, associated with increased incidence of pre-eclampsia, macrosomia, and cesarean delivery. Insulin therapy is the cornerstone treatment in those individuals with inadequate glycemic control by diet al...

Full description

Bibliographic Details
Main Authors: J. A. Villarreal-Rodriguez, L. G. Mancillas Adame, J. Maldonado-Sanchez, A. Guzmán-López, O. R. Treviño-Montemayor, J. G. Gonzalez-Gonzalez, D. Saldívar-Rodríguez
Format: Article
Language:English
Published: IMR Press 2020-08-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/47/4/10.31083/j.ceog.2020.04.5026
_version_ 1818005899598364672
author J. A. Villarreal-Rodriguez
L. G. Mancillas Adame
J. Maldonado-Sanchez
A. Guzmán-López
O. R. Treviño-Montemayor
J. G. Gonzalez-Gonzalez
D. Saldívar-Rodríguez
author_facet J. A. Villarreal-Rodriguez
L. G. Mancillas Adame
J. Maldonado-Sanchez
A. Guzmán-López
O. R. Treviño-Montemayor
J. G. Gonzalez-Gonzalez
D. Saldívar-Rodríguez
author_sort J. A. Villarreal-Rodriguez
collection DOAJ
description Introduction: Gestational diabetes (GD) is one of the most common medical complications of pregnancy, associated with increased incidence of pre-eclampsia, macrosomia, and cesarean delivery. Insulin therapy is the cornerstone treatment in those individuals with inadequate glycemic control by diet alone. The burden of insulin treatment includes the need for multiple injections, intensive blood glucose monitoring, risk of hypoglycemia, and emotional distress. Alternatives to insulin treatment have been studied in the past but there is limited previous experience with acarbose. Objective: To compare acarbose to insulin therapy and evaluate the proportion of subjects requiring rescue therapy with insulin due to inadequate glycemic control; as a secondary objective, pregnancy outcomes were assessed. Materials and Methods: Pregnant patients diagnosed with GD who failed glycemic control on dietetic treatment, were randomized to receive standard insulin therapy or acarbose. If the oral drug was not tolerated or glycemic goals were not met, standard insulin therapy was initiated. Results: A total of 104 patients were randomized (acarbose n = 40). Two patients in the acarbose group and six in the insulin group withdrew their consent before any study intervention due to personal preferences. In the acarbose group, 27/38 subjects (71%) achieved and maintained glycemic targets until delivery, while 11/38 (29%) received rescue insulin therapy and discontinued the study drug. No differences were found in birth weight, gestational age at birth, or Apgar score. Three patients in the acarbose and five in the insulin group presented perinatal complications. Conclusion: In this study, acarbose was found to be a safe and effective alternative to insulin therapy. Insulin therapy and its burden were avoided in over 70% of the GD patients failing nutritional therapy. Studies with a larger sample size and long-term follow-up are needed.
first_indexed 2024-04-14T04:52:44Z
format Article
id doaj.art-212d86fa7be74ea9814dd3c209953878
institution Directory Open Access Journal
issn 0390-6663
language English
last_indexed 2024-04-14T04:52:44Z
publishDate 2020-08-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj.art-212d86fa7be74ea9814dd3c2099538782022-12-22T02:11:14ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632020-08-0147455255510.31083/j.ceog.2020.04.5026S0390-6663(20)00309-7A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet aloneJ. A. Villarreal-Rodriguez0L. G. Mancillas Adame1J. Maldonado-Sanchez2A. Guzmán-López3O. R. Treviño-Montemayor4J. G. Gonzalez-Gonzalez5D. Saldívar-Rodríguez6Obstetrics and Gynecology Department, Maternal Fetal Medicine Division, School of Medicine and University Hospital “Dr. Jose Eleuterio Gonzalez”, MexicoInternal Medicine Department, Endocrinology Division, School of Medicine and University Hospital “Dr. Jose Eleuterio Gonzalez”, MexicoObstetrics and Gynecology Department, Maternal Fetal Medicine Division, School of Medicine and University Hospital “Dr. Jose Eleuterio Gonzalez”, MexicoObstetrics and Gynecology Department, Maternal Fetal Medicine Division, School of Medicine and University Hospital “Dr. Jose Eleuterio Gonzalez”, MexicoObstetrics and Gynecology Department, Maternal Fetal Medicine Division, School of Medicine and University Hospital “Dr. Jose Eleuterio Gonzalez”, MexicoInternal Medicine Department, Endocrinology Division, School of Medicine and University Hospital “Dr. Jose Eleuterio Gonzalez”, MexicoObstetrics and Gynecology Department, Maternal Fetal Medicine Division, School of Medicine and University Hospital “Dr. Jose Eleuterio Gonzalez”, MexicoIntroduction: Gestational diabetes (GD) is one of the most common medical complications of pregnancy, associated with increased incidence of pre-eclampsia, macrosomia, and cesarean delivery. Insulin therapy is the cornerstone treatment in those individuals with inadequate glycemic control by diet alone. The burden of insulin treatment includes the need for multiple injections, intensive blood glucose monitoring, risk of hypoglycemia, and emotional distress. Alternatives to insulin treatment have been studied in the past but there is limited previous experience with acarbose. Objective: To compare acarbose to insulin therapy and evaluate the proportion of subjects requiring rescue therapy with insulin due to inadequate glycemic control; as a secondary objective, pregnancy outcomes were assessed. Materials and Methods: Pregnant patients diagnosed with GD who failed glycemic control on dietetic treatment, were randomized to receive standard insulin therapy or acarbose. If the oral drug was not tolerated or glycemic goals were not met, standard insulin therapy was initiated. Results: A total of 104 patients were randomized (acarbose n = 40). Two patients in the acarbose group and six in the insulin group withdrew their consent before any study intervention due to personal preferences. In the acarbose group, 27/38 subjects (71%) achieved and maintained glycemic targets until delivery, while 11/38 (29%) received rescue insulin therapy and discontinued the study drug. No differences were found in birth weight, gestational age at birth, or Apgar score. Three patients in the acarbose and five in the insulin group presented perinatal complications. Conclusion: In this study, acarbose was found to be a safe and effective alternative to insulin therapy. Insulin therapy and its burden were avoided in over 70% of the GD patients failing nutritional therapy. Studies with a larger sample size and long-term follow-up are needed.https://www.imrpress.com/journal/CEOG/47/4/10.31083/j.ceog.2020.04.5026gestational diabetesinsulin treatmentacarbosepregnancy outcomes
spellingShingle J. A. Villarreal-Rodriguez
L. G. Mancillas Adame
J. Maldonado-Sanchez
A. Guzmán-López
O. R. Treviño-Montemayor
J. G. Gonzalez-Gonzalez
D. Saldívar-Rodríguez
A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone
Clinical and Experimental Obstetrics & Gynecology
gestational diabetes
insulin treatment
acarbose
pregnancy outcomes
title A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone
title_full A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone
title_fullStr A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone
title_full_unstemmed A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone
title_short A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone
title_sort randomized controlled trial comparing acarbose vs insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone
topic gestational diabetes
insulin treatment
acarbose
pregnancy outcomes
url https://www.imrpress.com/journal/CEOG/47/4/10.31083/j.ceog.2020.04.5026
work_keys_str_mv AT javillarrealrodriguez arandomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT lgmancillasadame arandomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT jmaldonadosanchez arandomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT aguzmanlopez arandomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT ortrevinomontemayor arandomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT jggonzalezgonzalez arandomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT dsaldivarrodriguez arandomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT javillarrealrodriguez randomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT lgmancillasadame randomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT jmaldonadosanchez randomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT aguzmanlopez randomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT ortrevinomontemayor randomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT jggonzalezgonzalez randomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone
AT dsaldivarrodriguez randomizedcontrolledtrialcomparingacarbosevsinsulintherapyforgestationaldiabetesinindividualswithinadequateglycemiccontrolbydietalone